00-BMT-123: A Phase III, Randomized, Paralled, Placebo-Controlled, Double-Blind, Multicenter Efficacy and Safety Study of Ramoplanin and Placebo in Neutropenic Oncology Patients.

Grants and Contracts Details

StatusFinished
Effective start/end date9/15/00 → 7/15/04

Funding

  • BioSearch: $30,600.00